Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Express Scripts
Healthtrust
UBS
Merck
QuintilesIMS
US Army
Moodys

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073209

« Back to Dashboard

NDA 073209 describes AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Barr, Mylan, Teva, Watson Labs, and Yaopharma Co Ltd, and is included in five NDAs. It is available from five suppliers. Additional details are available on the AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE profile page.

The generic ingredient in AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.
Summary for 073209
Tradename:AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Applicant:Mylan
Ingredient:amiloride hydrochloride; hydrochlorothiazide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 073209
Suppliers and Packaging for NDA: 073209
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE amiloride hydrochloride; hydrochlorothiazide TABLET;ORAL 073209 ANDA Mylan Pharmaceuticals Inc. 0378-0577 N 0378-0577-01
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE amiloride hydrochloride; hydrochlorothiazide TABLET;ORAL 073209 ANDA Mylan Pharmaceuticals Inc. 0378-0577 N 0378-0577-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG ANHYDROUS;50MG
Approval Date:Oct 31, 1991TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Teva
Accenture
UBS
Cerilliant
Colorcon
Daiichi Sankyo
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.